Fate Therapeutics (FATE) Non-Current Deferred Revenue (2015 - 2026)
Fate Therapeutics (FATE) reported Non-Current Deferred Revenue of $12.41 million for Q3 2022, down 61.9% from $32.56 million a year earlier and down 30.1% from the prior quarter.
Powered by 
Analysis
Fate Therapeutics (FATE) Non-Current Deferred Revenue (2015 - 2026) Analysis & Trends
At the end of FY2021, Fate Therapeutics posted Non-Current Deferred Revenue of $27.12 million, down 41.1% from FY2020.
- Non-Current Deferred Revenue has a five-year compound annual growth rate of 57.2% (FY2016 to FY2021).
- By year, Non-Current Deferred Revenue came in at $46.02 million in FY2020, $3.78 million in FY2019 (-49.7%), $7.5 million in FY2018 (+935.9%) and $724,000 in FY2017 (-74.4%).
- The Q3 2022 figure ranks as the lowest quarterly Non-Current Deferred Revenue since Q1 2020.
- Year over year, Non-Current Deferred Revenue has now declined in each of the last six quarters, with an average decline of 44.6% over the last six quarters.
- The high point for year-over-year Non-Current Deferred Revenue in five years was Q3 2020 (growth of 998.3%); the low point was Q1 2018 (a decline of 91.4%).
- Per Business Quant data, the three quarters before Q3 2022 came in at $17.74 million (Q2 2022), $22.53 million (Q1 2022) and $27.12 million (Q4 2021).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Fate Therapeutics | 215.18 Mn | 76.08 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 582,000.00 |
| Dec 31, 2025 | 381,000.00 |
| Sep 30, 2025 | 5,000.00 |
| Mar 31, 2025 | 212,000.00 |
| Dec 31, 2024 | 393,000.00 |
| Sep 30, 2024 | 600,000.00 |
| Mar 31, 2024 | 159,000.00 |
| Dec 31, 2023 | 685,000.00 |
| Sep 30, 2023 | 1.11 Mn |
| Jun 30, 2023 | 1.93 Mn |
| Sep 30, 2022 | 12.41 Mn |
| Jun 30, 2022 | 17.74 Mn |
| Mar 31, 2022 | 22.53 Mn |
| Dec 31, 2021 | 27.12 Mn |
| Sep 30, 2021 | 32.56 Mn |
| Jun 30, 2021 | 38.93 Mn |
| Mar 31, 2021 | 43.03 Mn |
| Dec 31, 2020 | 46.02 Mn |
| Sep 30, 2020 | 49.38 Mn |
| Jun 30, 2020 | 54.69 Mn |
API Access
Fate Therapeutics Non-Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=FATE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-deffered-revenue", "ticker": "FATE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=FATE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();